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Introduction / objectives
Extended-spectrum beta-lactamase-producing (ESBL)
Klebsiella spp. is a problematic nosocomical pathogen
around the world. In the present study, we aimed to evalu-
ate the previous use of antibiotics as a risk factor for isola-
tion of ESBL Klebsiella spp.
Methods
In aÂ retrospective case control study between June 2009
and June 2010 at Santa Casa de Misericórdia Hospital, city
of Ponta Grossa, south Brazil, 61 Klebsiella spp. (29 ESBL
and 32 controls non-ESBL-producing isolates) were
enrolled. ESBL were screened by disk diffusion method
and double disk approximation method, according to
CLSI. Prior use of antibiotic was analyzed in electronic
medical records. The antibiotic consumption (DDDs –
defined daily doses) was tested using the X
2 test (p <0.05).
Results
The DDDs of prior use and full use of cephalosporines,
fluoroquinolones, e metronidazole in ESBL and non-ESBL
groups were (122.02/145.77; 8.78/69.07), (15.66/22; 0.01/
26.2), (47.33/47.66; 3/28) respectively. Prior use of cepha-
losporines, fluoroquinolones, and metronidazole was
higher in ESBL-Klebsiella spp. than non-ESBL-Klebsiella
spp. (p<0,001). CarbapenemsÂ were not used by the
control group.
Conclusion
Theprior use of broad-spectrum cephalosporins, fluoro-
quinolones and metronidazole is an important risk factor
for acquisition of ESBL producing Klebsiella spp.
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